Scholarship: Fully-funded
Degree: Bachelor, Master, Ph.D
Nationality: International Students
Location: Hong Kong
Application deadlines: Open
Scholarship Description:
Professor Gu Shen returned to The Chinese University of Hong Kong’s School of Biomedical Sciences as an Assistant Professor in late 2019, also serving as an Assistant Professor in the Department of Obstetrics and Gynecology at Prince of Wales Hospital. He is a Fellow of the American College of Medical Genetics and Genomics (FACMG), a member of the American Society of Human Genetics, and holds dual certifications in Clinical Molecular Genetics and Genomics, and Clinical Cytogenetics and Genomics from the American Board of Medical Genetics and Genomics (ABMGG).
Dr. Gu obtained his bachelor’s and doctoral degrees from The Chinese University of Hong Kong, working under Professor Chan Wai-yee, the founding dean of the School of Biomedical Sciences and current vice president. His doctoral research focused on the epigenetic characterization and mechanisms using stem cell models. After graduating, he conducted postdoctoral research at Baylor College of Medicine under the esteemed geneticist James Lupski. He was admitted to the American Board of Medical Genetics and Genomics in 2016 and underwent three years of training in the Genetic Diagnostics Laboratory at Baylor, achieving dual certification in Clinical Molecular Genetics and Clinical Cytogenetics in 2019. He has published over 40 papers in high-impact journals, with more than 2,500 citations and a Google Scholar h-index of 26 and i10-index of 37 as of April 2025.
The group’s research has received multiple grants and support from the National Natural Science Foundation of China (NSFC), the Research Grants Council of Hong Kong (RGC), and the Hong Kong Health Medical Research Fund (HMRF).
Available Subjects:
- (1) identifying pathogenic gene variants in rare genetic diseases using exome and whole-genome sequencing;
- (2) employing CRISPR for precise gene editing and creating cell and animal models with patient-specific mutations to study the mechanisms of pathogenic gene variants; and
- (3) collaborating with hospitals to validate gene variants’ functions, aiding patients in drug selection and developing new gene therapies.
Eligibility criteria:
- Bachelor’s or master’s degree in a life sciences or medical-related field, with preference for those who have published papers.
- Extensive cell culture experience, with preference for candidates with CRISPR gene editing experience.
Application Procedure:
Please send your resume, undergraduate/graduate transcripts, research achievements/experience, language test scores, and published papers to the email:
